HUTCHMED (HCM) News Today GBX 236 -8.00 (-3.28%) (As of 11:53 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period HUTCHMED (China) Limited: HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA (fruquintinib)December 13, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Shares Down 3.7% - Here's What HappenedHUTCHMED (LON:HCM) Shares Down 3.7% - Should You Sell?December 12, 2024 | marketbeat.comHUTCHMED: ORPATHYS And TAGRISSO Get Breakthrough Therapy Designation In China For NSCLCDecember 12, 2024 | markets.businessinsider.comHUTCHMED Receives NMPA Conditional Approval For TYVYT Combination In Advanced Endometrial CancerDecember 4, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Announces Launch by Takeda of FRUZAQLA (fruquintinib) in JapanNovember 22, 2024 | finanznachrichten.deHUTCHMED To Receive Milestone Payment As Takeda Launches FRUZAQLA For Colorectal Cancer In JapanNovember 22, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - What's Next?November 16, 2024 | marketbeat.comHutchmed to receive $20M milestone payment from Takeda for Fruzaqla salesOctober 31, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Crosses Above 200 Day Moving Average - What's Next?October 16, 2024 | marketbeat.comHUTCHMED (China) Ltd (HCM) (Q2 2024) Earnings Call Highlights: Strong US Sales Propel Growth ...October 9, 2024 | finance.yahoo.comHUTCHMED (LON:HCM) Share Price Crosses Above 200 Day Moving Average of $284.47HUTCHMED (LON:HCM) Stock Crosses Above Two Hundred Day Moving Average of $284.47September 28, 2024 | marketbeat.comHUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by TakedaSeptember 24, 2024 | markets.businessinsider.comHutchmed Share Chat (HCM)September 20, 2024 | lse.co.ukHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average of $281.77HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average of $281.77September 4, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in ChinaAugust 31, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average of $280.85HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average of $280.85August 27, 2024 | marketbeat.comRobust Sales and Expansion Potential Underpin Buy Rating for HUTCHMEDAugust 5, 2024 | markets.businessinsider.com0J7G.IL,0P0001HOP9,145 (0J7G.IL)August 4, 2024 | ca.finance.yahoo.comHCM Aug 2024 25.000 callAugust 4, 2024 | ca.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) last week's 6.4% decline must have disappointed private equity firms who have a significant stakeJuly 29, 2024 | finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)May 15, 2024 | markets.businessinsider.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board CommitteeMay 8, 2024 | markets.businessinsider.comHUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five yearsApril 24, 2024 | finance.yahoo.comHUTCHMED (China) Ltd ADRApril 21, 2024 | morningstar.comLONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offerMarch 28, 2024 | lse.co.ukHCM Mar 2024 30.000 callMarch 15, 2024 | finance.yahoo.comHUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth PotentialFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | finanznachrichten.deHutchison China MediTech reports FY resultsFebruary 28, 2024 | msn.comHUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Turns To Profit In FY23, Revenue Surges; Stock Up In Pre-marketFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Ltd (H7T2.BE)February 20, 2024 | au.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) biggest owners are private equity firms who got richer after stock soared 4.3% last weekFebruary 20, 2024 | finance.yahoo.comWall Street Analysts See a 75.05% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?February 19, 2024 | msn.comMaintaining Hold on HUTCHMED: Mixed FRUTIGA Results and Fair Valuation Limit UpsideFebruary 7, 2024 | markets.businessinsider.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 2, 2024 | markets.businessinsider.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 2, 2024 | finance.yahoo.comHUTCHMED to Announce 2023 Final ResultsFebruary 1, 2024 | finance.yahoo.comHUTCHMED (China) Limited: HUTCHMED Receives ELUNATE (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal CancerJanuary 30, 2024 | finanznachrichten.deHUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong KongJanuary 30, 2024 | markets.businessinsider.comAfter Plunging -10.7% in 4 Weeks, Here's Why the Trend Might Reverse for HUTCHMED (HCM)January 18, 2024 | msn.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 30, 2023 | finance.yahoo.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 30, 2023 | finance.yahoo.comHUTCHMED (China) Limited - ADR (HCM) Price Target Increased by 5.11% to 26.63November 27, 2023 | msn.comHUTCHMED (China) Stock (NASDAQ:HCM), Analyst Ratings, Price Targets, PredictionsNovember 25, 2023 | benzinga.comHUTCHMED’s Global Expansion and New Product Launches Bolster Buy Rating: An Analysis of Growth Prospects and Market PotentialNovember 24, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)November 10, 2023 | markets.businessinsider.comHUTCHMED (China) Ltd HCMNovember 6, 2023 | morningstar.comHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023October 16, 2023 | benzinga.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode. >> Register for the Workshop Now HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.220.54▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼30▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITH News Today GRI News Today INDV News Today BMY News Today GPH News Today IGC News Today ARTL News Today PHAR News Today KOD News Today MRK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts